CLINICAL_TRIALS
trial_result
· 2019-07-19
Clinical Trial Update: Subarachnoid Administrations of Adults Autologous Mesenchymal Stromal Cells in SCI [Phase 1]
Summary
Phase 1 trial update on subarachnoid administration of autologous mesenchymal stromal cells for spinal cord injury; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Puerta de Hierro University Hospital | Conditions: Spinal Cord Injury | Phase 1 | Status: COMPLETED | Results posted: 2019-07-19